2024-05-14 11:45:30 ET
Summary
- Healthpeak (DOC) is an attractive healthcare REIT with a diverse portfolio and a yield of over 7%.
- The company is unlikely to see significant near-term AFFO growth, but offers stability and potential slight growth.
- The stock is currently undervalued and has a conservative double-digit upside, making it a good buy.
Dear subscribers,
Some continue to be dubious about investing in a REIT like Healthpeak ( DOC ), which I have been purchasing for the past 6 months, at prices below $17/share, which has led me to my current cost basis for the company of well below $17.5/share and a yield of over 7% for this BBB-rated equivalent REIT.
With its diverse portfolio of life science properties, outpatient medical care facilities, and continuing care retirement communities, it has a very interesting mix of assets, and is one of the more interesting healthcare REIT plays that we can see here....
Read the full article on Seeking Alpha
For further details see:
Healthpeak Q1 - The "Best" In The Space With A 15% Upside